NNM Securities

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE5172.20-32.5 (-0.62 %)

PREV CLOSE ( ) 5204.70

OPEN PRICE ( ) 5000.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 574

TODAY'S LOW / HIGH ( )5000.05 5216.15

52 WK LOW / HIGH ( )3102 7208

NSE5189.70-34.45 (-0.66 %)

PREV CLOSE( ) 5224.15

OPEN PRICE ( ) 5202.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 5189.70 (2)

VOLUME 22305

TODAY'S LOW / HIGH( ) 5130.50 5212.90

52 WK LOW / HIGH ( )3098 7220.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979

Management Info

Narayan K Seshadri - Chairman Sanjeev Kumar Panchal - Managing Director

Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore

Listing : BSE, NSE, MCX

NEWS

27Mar AstraZeneca Pharma gets nod to import
AstraZeneca Pharma India has received permission to import for sale and..

27Mar AstraZeneca Pharma surges on getting n
Astrazeneca Pharma India is currently trading at Rs. 5258.00, up by 198...

11Mar AstraZeneca Pharma India, Mankind Phar
AstraZeneca Pharma India and Mankind Pharma have entered into an agreeme..

11Mar Astrazeneca Pharma India informs about
Astrazeneca Pharma India has enclosed copy of press release in connectio..

20Feb AstraZeneca Pharma India informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	158	992.929999999999
Gross Profit	203.98	1341.05
Operating Profit	247.16	1914.27
Net Sales	3057.89	10029.71

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1455.20 (10.00%)	M.Cap (Rs. in Cr)846.88
Solara Active Pharma (BSE) 551.45 (16.32%)	M.Cap (Rs. in Cr)1985.01
Abbott India (BSE) 26131.85 (0.29%)	M.Cap (Rs. in Cr)55528.36
Windlas Biotech (BSE) 555.05 (6.97%)	M.Cap (Rs. in Cr)1154.42
Concord Biotech (BSE) 1595.25 (1.05%)	M.Cap (Rs. in Cr)16688.90

Shareholding Pattern

	PROMOTERS	75%
	NON-INSTITUTION	18.49%
	MUTUAL FUNDS/UTI	3.75%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Healthcare Fu...	2.34
ICICI Pru Innovatio...	0.93
Nippon India Small ...	0.76
Nippon India Pharma...	0.48
Motilal Oswal S&P B...	0.33
ICICI Pru MNC Fund(G)	0.19
Groww Nifty Total M...	0.02

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

Filing compliant on SCORES – Easy & quick